Literature DB >> 22932265

Detection of human papillomavirus among women in Laos: feasibility of using filter paper card and prevalence of high-risk types.

Keokedthong Phongsavan1, Inger Gustavsson, Lena Marions, Alongkone Phengsavanh, Rolf Wahlström, Ulf Gyllensten.   

Abstract

BACKGROUND: Persistent infection with high-risk (HR) human papillomavirus (HPV) is a well-recognized cause of cervical cancer, but little is known about the situation in Laos. The aims of the study were to determine the prevalence of HR-HPV among Lao women and to evaluate the use of a filter paper card (FTA Elute Micro Card) for collection of cervical cells in the humid tropical climate.
METHODS: This is a cross-sectional study including 1922 women from 3 provinces in Laos. During a gynecological examination, cervical cells were collected and applied to the FTA card followed by HPV typing using a real-time polymerase chain reaction (PCR)-based assay.
RESULTS: Overall, 213 of the 1922 women were positive for HR-HPV (11%). The most common type was the group HPV33/52/58 (3%), followed by the single type 16 (2%) and the group 18/45 (1%), respectively. Only 11 cards (0.6%) did not contain a sufficient amount of genomic DNA for polymerase chain reaction-based analysis.
CONCLUSIONS: The prevalence of HR-HPV infections in Laos is similar to other Asian countries, and 40% of the women with an HR-HPV infection will be target of the present HPV vaccines. The FTA card is suitable for collection of cervical cells for HR-HPV typing in tropical conditions. This information is important for planning and establishing primary and secondary prevention of cervical cancer in Laos.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22932265     DOI: 10.1097/IGC.0b013e3182664b6b

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  5 in total

1.  Cervical cytology and human papillomavirus among asymptomatic healthy volunteers in Vientiane, Lao PDR.

Authors:  Reika Takamatsu; Viengvansay Nabandith; Vatsana Pholsena; Phouthasone Mounthisone; Katsu Nakasone; Kentarou Ohtake; Naoki Yoshimi
Journal:  BMC Cancer       Date:  2017-12-19       Impact factor: 4.430

2.  Protein Detection Using the Multiplexed Proximity Extension Assay (PEA) from Plasma and Vaginal Fluid Applied to the Indicating FTA Elute Micro Card™.

Authors:  Malin Berggrund; Daniel Ekman; Inger Gustavsson; Karin Sundfeldt; Matts Olovsson; Stefan Enroth; Ulf Gyllensten
Journal:  J Circ Biomark       Date:  2016-01-01

3.  Efficacy of careHPV™ human papillomavirus screening versus conventional cytology tests for the detection of precancerous and cancerous cervical lesions among women living with HIV-1 in Lao People's Democratic Republic.

Authors:  Phimpha Paboriboune; Keokedthong Phongsavan; Phetsamone Arounlangsy; Bruno Flaissier; Oukham Aphayarath; Prasit Phimmasone; Ketmala Banchongphanith; Mixi Xayaovong; Gonzague Jourdain; Anne-Marie Schott; Mitra Saadatian-Elahi; Laurent Magaud; Amna Klich; Nicole Ngo-Giang-Huong; Isabelle Heard; Muriel Rabilloud; Valentina Sanchez Picot; Christophe Longuet
Journal:  Cancer Med       Date:  2022-03-08       Impact factor: 4.711

4.  The effect of Lactobacillus casei extract on cervical cancer cell lines.

Authors:  Soo-Nyung Kim; Won Moo Lee; Kyoung Sik Park; Jong Bin Kim; Dae Jong Han; Jaeman Bae
Journal:  Contemp Oncol (Pozn)       Date:  2015-08-13

5.  Feasibility and accuracy evaluation of three human papillomavirus assays for FTA card-based sampling: a pilot study in cervical cancer screening.

Authors:  Shao-Ming Wang; Shang-Ying Hu; Wen Chen; Feng Chen; Fang-Hui Zhao; Wei He; Xin-Ming Ma; Yu-Qing Zhang; Jian Wang; Priya Sivasubramaniam; You-Lin Qiao
Journal:  BMC Cancer       Date:  2015-11-04       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.